HYACORP MLF1® BODY CONTOURING

Product Description

HYACORP MLF1® BODY CONTOURING is an advanced absorbable skin implant designed explicitly for comprehensive body contouring applications. This sophisticated medical device represents a cutting-edge hyaluronic acid-based contouring implant manufactured by BioScience, adhering to stringent pharmaceutical standards. 

When you buy HYACORP body contouring MLF1, you receive a professional-grade body sculpting solution meticulously engineered to address volume deficits and contour irregularities in targeted body areas. Each HYACORP body contouring MLF1 1x10ml syringe contains high-purity, pharmaceutical-grade hyaluronic acid of non-animal origin, ensuring optimal biocompatibility and safety profiles for clinical applications.

HYACORP MLF1® BODY CONTOURING Dosage and Administration

Administration requires precise injection into the subcutaneous or supraperiosteal layer by qualified medical practitioners experienced in dermal filler techniques. The injection area must be thoroughly prepared using strict aseptic techniques to prevent contamination. Local or topical anesthesia may be applied to minimize patient discomfort during the contouring treatment procedure. Post-injection massage ensures uniform distribution throughout the treated area and optimal tissue integration.

Ingredient Information

Each mL contains 2.0mg hyaluronic acid, 20.0mg cross-linked hyaluronic acid, and 6.9mg sodium chloride in sterile water for injection. The body’s hyaluronic acid component derives from advanced bacterial fermentation processes, ensuring consistent molecular weight standards and exceptional purity. This specialized formulation provides optimal resistance to enzymatic degradation while maintaining essential viscoelastic properties for effective body sculpting applications.

Storage Instructions

Store between 2°C and 25°C in original packaging to maintain product integrity and sterility. Refrigerated storage optimizes shelf life and maintains optimal viscosity characteristics. Allow the product to reach room temperature before administration to ensure optimal performance characteristics and patient comfort.

HYACORP MLF1® BODY CONTOURING Contraindications

Contraindications include known hypersensitivity to hyaluronic acid or product components, active skin infections in the injection area, autoimmune diseases, and bleeding disorders. Pregnant or lactating women should not receive treatment due to insufficient safety data. Patients under 18 years of age require careful evaluation due to the limited safety and efficacy data available in pediatric populations.

HYACORP MLF1® BODY CONTOURING Precautions and Warnings

Medical practitioners must possess appropriate training and experience in dermal filler injection techniques before product administration. Strict aseptic technique prevents infection risks during all procedures. Emergency medications and equipment should remain readily available throughout treatment sessions. Careful attention to vascular anatomy prevents serious intravascular injection complications.

HYACORP MLF1® BODY CONTOURING Manufacturer and Regulatory Information

BioScience GmbH manufactures this product under strict pharmaceutical standards and quality control protocols. The company maintains ISO certification and complies with European medical device regulations. Each batch undergoes comprehensive quality assurance procedures. CE marking indicates conformity with European health and safety standards, ensuring practitioners receive consistent products when they order from authorized suppliers.